vs

Side-by-side financial comparison of ACACIA RESEARCH CORP (ACTG) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $50.1M, roughly 1.5× ACACIA RESEARCH CORP). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 2.6%). Over the past eight quarters, ACACIA RESEARCH CORP's revenue compounded faster (43.6% CAGR vs 31.3%).

Acacia Research Corporation is a publicly traded American company based in New York City. It acquires and operates businesses in industries including the technology, energy, and industrial/manufacturing sectors. Acacia has a strategic relationship with Starboard Value, LP, the company's controlling shareholder. The company has been characterized as a patent troll.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

ACTG vs PBYI — Head-to-Head

Bigger by revenue
PBYI
PBYI
1.5× larger
PBYI
$75.5M
$50.1M
ACTG
Growing faster (revenue YoY)
PBYI
PBYI
+25.1% gap
PBYI
27.7%
2.6%
ACTG
Faster 2-yr revenue CAGR
ACTG
ACTG
Annualised
ACTG
43.6%
31.3%
PBYI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACTG
ACTG
PBYI
PBYI
Revenue
$50.1M
$75.5M
Net Profit
$3.4M
Gross Margin
12.8%
69.3%
Operating Margin
-26.1%
22.7%
Net Margin
6.8%
Revenue YoY
2.6%
27.7%
Net Profit YoY
125.5%
EPS (diluted)
$0.03
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACTG
ACTG
PBYI
PBYI
Q4 25
$50.1M
$75.5M
Q3 25
$59.4M
$54.5M
Q2 25
$51.2M
$52.4M
Q1 25
$124.4M
$46.0M
Q4 24
$48.8M
$59.1M
Q3 24
$23.3M
$80.5M
Q2 24
$25.8M
$47.1M
Q1 24
$24.3M
$43.8M
Net Profit
ACTG
ACTG
PBYI
PBYI
Q4 25
$3.4M
Q3 25
$-2.7M
$8.8M
Q2 25
$-3.3M
$5.9M
Q1 25
$24.3M
$3.0M
Q4 24
$-13.4M
Q3 24
$-14.0M
$20.3M
Q2 24
$-8.4M
$-4.5M
Q1 24
$-186.0K
$-4.8M
Gross Margin
ACTG
ACTG
PBYI
PBYI
Q4 25
12.8%
69.3%
Q3 25
21.2%
77.7%
Q2 25
12.8%
76.5%
Q1 25
47.4%
77.1%
Q4 24
17.6%
76.4%
Q3 24
10.1%
63.9%
Q2 24
26.2%
77.4%
Q1 24
49.2%
75.5%
Operating Margin
ACTG
ACTG
PBYI
PBYI
Q4 25
-26.1%
22.7%
Q3 25
-10.8%
17.6%
Q2 25
-24.2%
12.7%
Q1 25
30.8%
8.7%
Q4 24
-32.4%
22.6%
Q3 24
-44.1%
27.4%
Q2 24
-18.4%
-4.6%
Q1 24
-8.6%
-5.3%
Net Margin
ACTG
ACTG
PBYI
PBYI
Q4 25
6.8%
Q3 25
-4.6%
16.2%
Q2 25
-6.4%
11.2%
Q1 25
19.5%
6.5%
Q4 24
-27.5%
Q3 24
-60.0%
25.2%
Q2 24
-32.7%
-9.6%
Q1 24
-0.8%
-11.0%
EPS (diluted)
ACTG
ACTG
PBYI
PBYI
Q4 25
$0.03
$0.26
Q3 25
$-0.03
$0.17
Q2 25
$-0.03
$0.12
Q1 25
$0.25
$0.06
Q4 24
$-0.14
$0.40
Q3 24
$-0.14
$0.41
Q2 24
$-0.08
$-0.09
Q1 24
$0.00
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACTG
ACTG
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$306.7M
$97.5M
Total DebtLower is stronger
$91.9M
$22.7M
Stockholders' EquityBook value
$543.5M
$130.3M
Total Assets
$771.0M
$216.3M
Debt / EquityLower = less leverage
0.17×
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACTG
ACTG
PBYI
PBYI
Q4 25
$306.7M
$97.5M
Q3 25
$301.8M
$94.4M
Q2 25
$316.7M
$96.0M
Q1 25
$272.0M
$93.2M
Q4 24
$273.9M
$101.0M
Q3 24
$410.9M
$96.7M
Q2 24
$441.9M
$96.8M
Q1 24
$498.4M
$107.2M
Total Debt
ACTG
ACTG
PBYI
PBYI
Q4 25
$91.9M
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
ACTG
ACTG
PBYI
PBYI
Q4 25
$543.5M
$130.3M
Q3 25
$537.6M
$115.3M
Q2 25
$538.6M
$104.7M
Q1 25
$540.2M
$97.1M
Q4 24
$514.8M
$92.1M
Q3 24
$540.2M
$71.1M
Q2 24
$560.7M
$48.5M
Q1 24
$568.3M
$51.0M
Total Assets
ACTG
ACTG
PBYI
PBYI
Q4 25
$771.0M
$216.3M
Q3 25
$768.9M
$202.9M
Q2 25
$775.5M
$194.9M
Q1 25
$801.6M
$196.2M
Q4 24
$756.4M
$213.3M
Q3 24
$707.6M
$220.7M
Q2 24
$753.6M
$205.0M
Q1 24
$631.7M
$214.1M
Debt / Equity
ACTG
ACTG
PBYI
PBYI
Q4 25
0.17×
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACTG
ACTG
PBYI
PBYI
Operating Cash FlowLast quarter
$75.2M
$14.4M
Free Cash FlowOCF − Capex
$14.4M
FCF MarginFCF / Revenue
19.1%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
22.01×
TTM Free Cash FlowTrailing 4 quarters
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACTG
ACTG
PBYI
PBYI
Q4 25
$75.2M
$14.4M
Q3 25
$9.5M
$9.7M
Q2 25
$50.1M
$14.1M
Q1 25
$2.4M
$3.6M
Q4 24
$50.1M
$15.6M
Q3 24
$-593.0K
$11.0M
Q2 24
$16.1M
$1.0M
Q1 24
$54.8M
$11.2M
Free Cash Flow
ACTG
ACTG
PBYI
PBYI
Q4 25
$14.4M
Q3 25
$9.7M
Q2 25
$14.1M
Q1 25
$335.0K
$3.6M
Q4 24
$-98.5M
$15.6M
Q3 24
$-2.8M
$11.0M
Q2 24
$-126.7M
$1.0M
Q1 24
$54.6M
FCF Margin
ACTG
ACTG
PBYI
PBYI
Q4 25
19.1%
Q3 25
17.7%
Q2 25
26.8%
Q1 25
0.3%
7.7%
Q4 24
-201.8%
26.4%
Q3 24
-12.1%
13.7%
Q2 24
-490.5%
2.1%
Q1 24
224.4%
Capex Intensity
ACTG
ACTG
PBYI
PBYI
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
1.7%
0.1%
Q4 24
304.4%
0.0%
Q3 24
9.6%
0.0%
Q2 24
553.0%
0.0%
Q1 24
1.1%
0.0%
Cash Conversion
ACTG
ACTG
PBYI
PBYI
Q4 25
22.01×
Q3 25
1.10×
Q2 25
2.41×
Q1 25
0.10×
1.21×
Q4 24
Q3 24
0.54×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACTG
ACTG

Energy Operations$16.0M32%
Transportation Safety$10.4M21%
Office Storage And Display Solutions$8.4M17%
Printers Consumables And Parts$6.5M13%
Natural Gas Reserves$5.1M10%
Natural Gas Liquids Reserves$3.3M7%

PBYI
PBYI

Segment breakdown not available.

Related Comparisons